PHILIP-MORRIS-INTERNATIO
Philip Morris International Inc. (PMI ) (NYSE: PM) today released the latest Scientific Update for Smoke-Free Products , a regular publication on its research efforts to develop and assess a range of smoke-free alternatives to cigarettes.
We are focusing this issue on the growing body of independent research on our electrically heated tobacco product (EHTP, marketed as IQOS ), the most advanced smoke-free alternative in our portfolio. The covered research comprises independent, peer-reviewed publications on smoke-free products that focus on EHTP, and also includes four recent government reports from the UK, the US, Germany, and the Netherlands. Other sections include an update on the assessment of each product in our smoke-free portfolio, recent R&D milestones and a compendium of PMI’s peer-reviewed publications on its smoke-free products this year.
“We are happy to see growing interest in studying our smoke-free products and that the general trend among independent results is in line with our own research,” said Prof. Manuel Peitsch, PMI’s Chief Scientific Officer. “Independent research on our electronically heated tobacco product, ETHP, demonstrates significant improvements relative to cigarettes, and is crucial to our efforts to change the lives of millions of smokers around the world.”
PMI’s extensive research and assessment program is inspired by the well-recognized practices of the pharmaceutical industry and in line with the draft guidance of the U.S. FDA for Modified Risk Tobacco Product (MRTP) Applications. PMI employs over 400 world-class scientists, engineers and experts in a variety of research and development disciplines, and has published over 250 scientific publications in peer-reviewed journal and book chapters on smoke-free products.
Philip Morris International: Who We Are
We are a leading international tobacco company engaged in the manufacture and sale of cigarettes and other nicotine-containing products in markets outside the United States of America. We’re building our future on smoke-free products that are a much better choice than continuing to smoke cigarettes. Through multidisciplinary capabilities in product development, state-of-the-art facilities and scientific substantiation, we aim to ensure that our smoke-free products meet adult consumer preferences and rigorous regulatory requirements. Our vision is that these products ultimately replace cigarettes to the benefit of adult smokers, society, our company and our shareholders. For more information, see our PMI and PMIScience websites.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180606005758/en/
Contact:
Philip Morris International media office
T: +41 (0)58 242 4500
E:
joshua.townsend@pmi.com
E:
jana.olson@pmi.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Geoswift Launches Visa Direct to Enhance Cross-Border Payment Offers in Over 30 Countries30.4.2025 03:00:00 CEST | Press release
Geoswift announced today the integration of Visa Direct with Geoswift's cross-border payments platform. Visa Direct facilitates payouts to more than 140 countries and territories. The integration will enable payouts in 32 countries and territories, across 13 currencies, covering major markets in Asia Pacific, North America, Europe and Middle East, with plans for more in the future. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250423288249/en/ Bryan Ma, SVP, Head of Geoswift Global Payments, and Swapnil Mhasde, Head of Visa Direct Commercialization and Solutions, Asia Pacific, celebrating the launch in Singapore. Geoswift is a leading provider of cross-border payment services and solutions globally. With over two decades of innovation, it has become a trusted name in B2B, education, eCommerce, remittance, and travel payment use cases. Raymond Qu, Group CEO of Geoswift, stated, "At Geoswift, our vision has always been to del
Logitech Announces Q4 and Full Fiscal Year 2025 Results29.4.2025 22:03:00 CEST | Press release
A Year of Broad-Based Sales Growth, Expanded Market Share and Increased Profitability, Driven by Strategic Priorities SIX Swiss Exchange Ad hoc announcement pursuant to Art. 53 LR — Logitech International (SIX: LOGN) (Nasdaq: LOGI) today announced financial results for the fourth quarter and full Fiscal Year 2025 ended March 31, 2025. For Fiscal Year 2025: Sales were $4.55 billion, up 6 percent in US dollars and 7 percent in constant currency, compared to the prior year. GAAP operating income was $655 million, up 11 percent compared to the prior year. Non-GAAP operating income was $775 million, up 11 percent compared to the prior year. GAAP earnings per share (EPS) was $4.13, up 7 percent compared to the prior year. Non-GAAP EPS was $4.84, up 14 percent compared to the prior year. Cash flow from operations was $843 million. The year-ending cash balance was $1.5 billion. The Company returned $797 million of cash to shareholders through its annual dividend payment and share repurchases.
U.S. Patent and Trademark Office Invalidates Pharmacyclics Patent Asserted Against BeiGene29.4.2025 21:32:00 CEST | Press release
BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced that the U.S. Patent and Trademark Office (USPTO) rendered a Final Written Decision invalidating all claims of Pharmacyclics LLC’s (Pharmacyclics) U.S. Patent No. 11,672,803 (the ‘803 patent) that were challenged by BeiGene in a post-grant review (PGR) proceeding. On November 1, 2023, BeiGene filed a PGR petition with the USPTO challenging the validity of certain claims of the ‘803 patent, in response to a patent infringement lawsuit Pharmacyclics brought against BeiGene concerning BRUKINSA® (zanubrutinib). On May 1, 2024, the USPTO granted BeiGene’s petition to institute the PGR. The USPTO’s Final Written Decision is appealable by Pharmacyclics. Commenting on the ruling, BeiGene General Counsel Chan Lee said: “We are pleased that the USPTO invalidated all challenged claims of the ‘803 patent. Today’s decision reinforces our belief th
One out of Three Secure Civil IDs Delivered Each Year Is Powered by Thales29.4.2025 16:50:00 CEST | Press release
In a world where identity fraud represents a critical vulnerability for citizens and societies, Thales is leading the transformation of civil identity into a secure and citizen-first service. Through its advanced Civil Identity Suite, Thales enables governments worldwide to protect their citizens, ensuring protection at every stage of the identity journey and for the entire identity chain. Supporting more than 300 national identity programmes and having enrolled over 500 million people, Thales is uniquely positioned to deliver secure and responsible identity solutions. Each year, Thales powers one in three smart civil IDs (official electronic documents) issued worldwide, highlighting the company’s key role in shaping the future of identities and helping governments and citizens transition smoothly to digital. With its Civil Identity Suite, Thalesenables the issuance and management of both physical and digital identities, as well as all means of enrolling citizens and enabling seamless
Solving Border Control Staffing Challenges: Regula Launches an Ecosystem for Remote Document Examination29.4.2025 15:00:00 CEST | Press release
Regula, a global developer of forensic devices and identity verification solutions, introduces an innovative solution designed to transform document examination processes, particularly in border control operations. Based on high-resolution photospectral scanners from the Regula 88XX product line, it enables highly accurate and reliable remote document authentication, effectively addressing the pressing issue of staffing shortages in border security. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250429852027/en/ High-resolution photospectral scanner Regula 8880 for remote document verification (Photo: Regula) Traditionally, document authenticity experts needed to be physically present at each checkpoint. However, this requirement has become increasingly challenging due to current staffing constraints. For example, a recent European Commission report highlights gaps in the availability of certain specialized experts, notably
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom